## Common ground
Both options refer to the same active pharmaceutical ingredient—chloroquine or hydroxychloroquine sulphate—differing only in form and packaging.
## Options at a glance
**2933.49 – Bulk form**
- **Defining trait:** Sold as raw, unmeasured chemical substance, not intended for direct patient use.
- **Typical examples:** Pharmaceutical intermediates, bulk powder for manufacturing.
- **Best fit when:** The product is shipped or used in industrial or laboratory settings without dosage control.
**3004.90 – Retail-ready medicaments**
- **Defining trait:** Pre-packaged in individual doses (e.g., tablets, capsules) for direct patient use.
- **Typical examples:** Tablets labeled with dose (e.g., 200 mg), blister packs, or bottles sold in pharmacies.
- **Best fit when:** The product is intended for end consumers or healthcare providers for immediate medical use.
## Key differences
| Criteria | 2933.49 – Bulk form | 3004.90 – Retail-ready medicaments |
|----------------------|-------------------------------|-------------------------------------|
| Packaging | Unpackaged or bulk containers | Individual doses, retail packaging |
| Dosage control | None | Pre-measured |
| End use | Manufacturing/Research | Direct patient administration |
## How to choose
- Is the product sold in large quantities without individual dosing? → 2933.49
- Is it packaged in tablets, capsules, or bottles for sale to patients? → 3004.90
## Overlaps & pitfalls
A product may appear to fit both if it’s a bulk shipment of pre-dosed tablets—however, the key is whether the dosing is fixed and intended for direct use. If the product is labeled with dose strength and sold in retail form, it belongs under 3004.90 regardless of quantity. The main function (manufacturing vs. patient use) determines the correct code. No priority rule can be assumed; choose based on the product’s primary purpose